The novel platform for chemoimmunotherapy eliminated colon cancer in 85 percent of treated mice.
Rosemary (Rosie) Clandos is a contributing health and science writer. She has written for the Los Angeles Times, Kaiser Permanente, U.S. Department of Defense, National Science Foundation, and several universities and medical centers on the West Coast. Rosie has covered topics ranging from medicine to microelectromechanical systems. As the author of “Health Hunt on the Internet: Find and Use Reliable Medical Information,” she specializes in compelling storytelling.
New research documents how chemicals and a certain gene activate an enzyme to increase the risk and severity of RA and bone destruction.
A large randomized trial finds Keytruda given with chemotherapy resulted in 20 percent improved survival at one year.
A decadelong effort to genomically characterize multiple cancers begets a huge archive: 33 cancer types, 11,000 tumors and 27 new papers that explain the findings.
Personalized dosing of omega-3 fatty acids decreases prostaglandin E2 in the colon, but the beneficial effects are smaller in overweight people, research finds.